Literature DB >> 2586012

Rapid onset of uricosuria after oral administration of irtemazole, an uricosuric substance.

U Gresser1, U Kronawitter, O Adjan, N Zöllner.   

Abstract

A single 50 mg dose of irtemazole was given orally to ten healthy male volunteers. The onset of effects was tested. Plasma uric acid began to decrease 15 to 25 min after irtemazole was administrated. Renal uric acid excretion and uric acid clearance increased 10 to 20 min after drug administration. Maximal renal uric acid excretion (mean 197.4 mg/h) and maximal uric acid clearance (mean 78.4 ml/min) were reached after 15 to 55 min. No side effects were observed. The effects of irtemazole occur earlier than those of benzbromarone. The therapeutic effects of long-term therapy remain to be investigated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2586012     DOI: 10.1007/bf01727008

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  7 in total

1.  Enzymatic determination of uric acid; with detailed directions.

Authors:  E PRAETORIUS; H POULSEN
Journal:  Scand J Clin Lab Invest       Date:  1953       Impact factor: 1.713

2.  Uricosuric effect of irtemazole in hyperuricemic patients without and with renal insufficiency.

Authors:  I Kamilli; U Gresser; T Pellkofer; W Löffler; N Zöllner
Journal:  Z Rheumatol       Date:  1989 Nov-Dec       Impact factor: 1.372

3.  Effect of single oral doses of benzbromarone on serum and urinary uric acid.

Authors:  A K Jain; J R Ryan; F G McMahon; R J Noveck
Journal:  Arthritis Rheum       Date:  1974 Mar-Apr

4.  [Effect of benzbromaronum on the renal uric acid excretion in healthy persons].

Authors:  N Zöllner; W Dofel; W Gröbner
Journal:  Klin Wochenschr       Date:  1970-04-01

5.  Uricosuric effect of irtemazole in healthy subjects.

Authors:  U Gresser; N Zöllner
Journal:  Klin Wochenschr       Date:  1989-10-02

Review 6.  Benzbromarone: a review of its pharmacological properties and therapeutic use in gout and hyperuricaemia.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-11       Impact factor: 9.546

7.  A new uricosuric substance 5-[(1H-imidazol-1-yl)phenylmethyl]-2-methyl-1H-benzimidazole (C18H16N4).

Authors:  U Gresser; N Zöllner
Journal:  Klin Wochenschr       Date:  1989-06-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.